DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Miller TM, Pestronk A, David W. et al.
An antisense oligonucleotide against SOD1 delivered intrathecally for patients
with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised,
first-in-man study.
Lancet Neurol 2013;
12: 435-442
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.